Conjunctivitis Journals
Conjunctivitis means
inflammation and swelling of the thin, clear layer that covers the white of your eye and lines your eyelid (the conjunctiva). It can make your eyes look red, feel gritty and be watery or sticky. It’s sometimes called pink eye. Conjunctivitis is common, especially in children. It usually gets better on its own within a week or so. There are things you can do to ease your symptoms, often with the help of treatments you can get from your pharmacist. You don’t usually need to see your GP for conjunctivitis, but there are some occasions when it’s important to seek medical advice. There are three main types of conjunctivitis such as, infective conjunctivitis, which may be caused by
viruses or bacteria, allergic conjunctivitis, for instance as part of hay fever if you’re allergic to pollen', irritant (chemical) conjunctivitis, when your eyes come into contact with something which irritates them (for example, chlorine in swimming pools). Allergic Conjunctivitis are Usually occurs in both eyes, Can produce intense itching, tearing, and swelling in the eyes, May occur with symptoms of allergies, such as an itchy nose, sneezing, a scratchy throat, or asthma. Viral Conjunctivitis can occur with symptoms of a cold, flu, or other respiratory infection, Usually begins in one eye and may spread to the other eye within days, Discharge from the eye is usually watery rather than thick.
High Impact List of Articles
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Engaging patients for drug repurposing: mapping the patients engagement continuum
Minna Allarakhia
Editorial: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Two decades testing interventions in transgenic mouse models of Alzheimers disease: designing and interpreting studies for clinical trial success
Kieren Egan, & Malcolm Macleod
Clinical Trail Methodology: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Joseph Kuti
Joseph Kuti
Interview: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
-
Sodium,glucose cotransporter 2 inhibitors in the treatment of Type 2 diabetes: a review of Phase II and III trials
Mark S Kipnes
Review Article: Clinical Investigation
Relevant Topics in Clinical